[A clinical-therapeutic study on high dose lidaprim tablets in severe bacterial infections].
D000328:Adult; D000419:Albuminuria; D001424:Bacterial Infections / Q000188:drug therapy*; D004338:Drug Combinations; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004361:Drug Tolerance; D004890:Erythema / Q000139:chemically induced; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D008297:Male; D011537:Pruritus / Q000139:chemically induced; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013424:Sulfanilamides / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000188:drug therapy; D014295:Trimethoprim / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy; D014581:Urticaria / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D004338:Drug Combinations; D013424:Sulfanilamides; D014295:Trimethoprim
Eine klinisch-therapeutische Untersuchung mit Lidaprim -Tabletten in einer hohen Dosierung bei schweren Infektionen bakterieller Genese.